LONDON, United Kingdom — Britain’s Queen Elizabeth II will receive the Pfizer-BioNTech coronavirus vaccine within weeks, according to reports, after the kingdom regulators granted emergency approval
The monarch, 94, and her 99-year-old husband Prince Philip are in line to get the jab early due to their age and will not receive preferential treatment, the Mail on Sunday reported.
The newspaper said Britain’s most senior royals would reveal they have been given the inoculation “to encourage more people to take up the vital jab”, amid fears so-called anti-vaxxers could dent enthusiasm for it.
Earlier this week, Fizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, according to sources, following similar steps in the United States and Britain, the companies said on Tuesday.
The application came weeks after the drug maker projected promising result in phase 3 trial of its COVID-19 vaccine, sharing joy over a 90 percent victory in the war against growing respiratory illness.
The company has previously sought the United States on Nov. 20, taking them a step closer to launching their vaccine for public use.
In their pursuit of a European launch, potentially this year, the partners are neck-and-neck with rival Moderna, which said on Monday it would ask the EU regulator to recommend conditional approval for its shot, as Reuters reported.
The British government said last week that the U.S.-German partners had reported the data from their clinical trials to the UK Medicines and Healthcare products Regulatory Agency (MHRA), the report further wrote.